2026 Pathology Quality Measures

The Pathologists Quality Registry offers 13 quality measures. Seven are Merit-based Incentive Payment System (MIPS) clinical quality measures (CQMs). The remaining six are pathology measures developed by the CAP and approved by the CMS as qualified clinical data registry (QCDR) measures—exclusively available in the Pathologists Quality Registry. To better understand how to review and interpret measure specifications, the CMS has developed Quality Payment Program Measure Specification and Measure Flow Guide for MIPS Clinical Quality Measures.

Important 2026 Updates

CAP 22: Biopsy Reporting Time to Clinician is no longer available in the program.
CAP 38: Prostate Cancer Reporting: Complete Analysis is no longer available in the program
CAP 41: Basal Cell Skin Cancer: Complete Reporting is no longer available in the program

Pathology Specific QPP Measures

These measures can be reported to the CMS using the Pathologists Quality Registry, through billing/claims, and other registries.

QPP 249: Barrett Esophagus Pathology Reporting Registry and Claims Specifications
QPP 250: Radical Prostatectomy Pathology Reporting Registry and Claims Specifications
QPP 395: Lung Cancer Reporting (biopsy/cytology specimens) Registry and Claims Specifications
QPP 396: Lung Cancer Reporting (resection specimens) Registry and Claims Specifications
QPP 397: Melanoma Reporting Registry and Claims Specifications

These measures can be reported to the CMS using the Pathologists Quality Registry and other registries.

QPP 440: Skin Cancer: Biopsy Reporting Time - Pathologist to Clinician Registry Specifications (American Academy of Dermatology measure)
QPP 491: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma Registry Specifications

Scores for the QPP measures depend on the benchmarks CMS sets for each measure. Estimate your score by viewing the QPP Measure Benchmarks.

Pathologists Quality Registry QCDR Measures

These measures can be reported to the CMS only with the Pathologists Quality Registry.

CAP 30: Urinary Bladder Cancer Complete Analysis and Timely Reporting
CAP 34: Molecular Assessment Biomarkers Non-Small Cell Lung Cancer
CAP 40: Squamous Cell Skin Cancer Complete Reporting
CAP 42: Barrett's Esophagus Complete Analysis with Appropriate Consultation
CAP 43: Complete Reporting of Gastrointestinal Metaplasia
CAP 44: Molecular Assessment for Endometrial Carcinoma

For 2025, three QCDR measures have historical benchmarks. Estimate your score by viewing the QCDR Measure Benchmarks

2025 Pathology Quality Measures Frequently Asked Questions

The CMS recommends that eligible professionals check with the QPP HelpDesk for more information on measures and the QPP.

Professionals may contact the QPP Help Desk.
7:00 AM–7:00 PM CT Monday - Friday
Email: QPP@cms.hhs.gov
Phone: 866-288-8292

Suggest New Quality Measures

The CAP wants to know what matters to pathologists for quality measures. Submit your ideas for measure concepts today! Access the measure concept intake form or contact measures@cap.org for more information about nominating a concept.

Claims-Based Reporting Information

The CAP developed an instruction sheet on claims-based reporting to assist with submitting data on quality measures for MIPS through claims. The corresponding document provides the CPT II and quality data codes (QDC) and descriptors for the 2026 QPP measures.

For the 2025 Reporting Period

Pathologists in a group of 16 or more clinicians cannot submit quality measures using claims regardless of whether participating as an individual or a group.

Find out more about the Pathologists Quality Registry Right Arrow